US Patent Issued to Washington University on Aug. 18 for "Method to risk-stratify oligometastatic non-small cell lung cancer patients using cell-free DNA liquid biopsies" (Missouri Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,777, issued on Aug. 18, was assigned to Washington University (St. Louis).

"Method to risk-stratify oligometastatic non-small cell lung cancer patients using cell-free DNA liquid biopsies" was invented by Aadel Chaudhuri (St. Louis) and Nicholas Semenkovich (St. Louis).

According to the abstract* released by the U.S. Patent & Trademark Office: "Among the various aspects of the present disclosure is the provision of a method to risk-stratify cancer patients using circulating DNA assays. In other aspects, a method of selecting treatment for an early-stage non-small cell lung cancer for a patient in need that includes subjecting a blood sample from a patient to a liquid biopsy assay...